000026413 000__ 05335cam\a2200553\i\4500
000026413 001__ 26413
000026413 003__ SzGeWIPO
000026413 005__ 20230203215935.0
000026413 008__ 080908s2008\\\\enka\\\\rb\\\\001\0\eng\\
000026413 020__ $$a9781848440777
000026413 020__ $$z1848440774
000026413 020__ $$z9781848444898$$qelectronic book
000026413 020__ $$z1848444893$$qelectronic book
000026413 020__ $$z1281941387
000026413 020__ $$z9781281941381
000026413 035__ $$a(wipo)0
000026413 035__ $$a(OCoLC)246917440
000026413 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026413 041__ $$aeng
000026413 043__ $$ad------
000026413 050_4 $$aRA643.86.D44$$bP65 2008
000026413 08204 $$a362.19697920091724$$222
000026413 084__ $$aG 99 COR.P
000026413 090__ $$c28806$$d28796
000026413 1001_ $$aCoriat, Benjamin.$$eEditor.
000026413 24514 $$aThe Political Economy of HIV/AIDS in Developing Countries :$$bTRIPS, Public Health Systems and Free Access.
000026413 264_1 $$aCheltenham, UK :$$bEdward Elgar,$$c2008.
000026413 300__ $$a352 pages :$$billustrations ;$$c25 cm
000026413 336__ $$atext$$btxt$$2rdacontent
000026413 337__ $$aunmediated$$bn$$2rdamedia
000026413 338__ $$avolume$$bnc$$2rdacarrier
000026413 504__ $$aIncludes bibliographical references and index.
000026413 5050_ $$aForeword -- Introduction: A New Stage in the Fight against the HIV/AIDS Pandemic – An Economic Perspective -- Part I: Trips, Generic Drugs and Access to Care: The Post-2005 Issues -- 1. New Antiretroviral Treatments and Post-2005 TRIPS Constraints: First Moves towards IP Flexibilization in Developing Countries -- 2. New Trends in IP Protection and Health Issues in FTA Negotiations -- 3. Evolution of Prices and Quantities for ARV Drugs in African Countries: From Emerging to Strategic Markets -- Part II: Securing Free and Universal Access: Lessons From Brazil -- 4. The Brazilian Experience of ‘Scaling-up’: A Public Policy Approach -- 5. Technology Transfer Agreements and Access to HIV/AIDS Drugs: The Brazilian Case -- 6. Scaling Up and Reverse Engineering: Acquisition of Industrial Knowledge by Copying Drugs in Brazil -- 7. Compulsory Licensing in the Real World: The Case of ARV Drugs in Brazil -- Part III: Fighting Aids in the Heart of the Pandemic: Sub-Saharan and Low-Income Countries -- 8. HIV Prevalence Estimates: The New Deal in Sub-Saharan Africa since 2000 -- 9. Cost-effectiveness of HIV Antiretroviral Therapies in Resource-limited Settings -- 10. ‘Fragility’: A Macro-dynamic Motive to Offer Quick and General Access to ART in LDC -- 11. Procurement Policies, Governance Models and ARV Availability in French-speaking African Countries: An Overview -- Part IV: Building the Future: Public Health Systems and the Free Access Challenge -- 12. The Public Health Approach to Antitretroviral Treatment: The Case of Cameroon -- 13. The Cost of Universal Free Access for Treating HIV/AIDS in Low-Income Countries: The Case of Senegal -- 14. Implementing Funding Modalities for Free Access: The Case for a ‘Purchasing Fund System’ to Cover Medical Care for PLWHA -- Index
000026413 520__ $$aThe issue of universal and free access to treatment is now a fundamental goal of the international community. Based on original data and field studies from Brazil, Thailand, India and Sub-Saharan Africa under the aegis of ANRS (the French nationalagency for research on Aids and viral hepatitis, this timely and significant book both assesses the progress made in achieving this objective and presents a rigorous diagnosis of the obstacles that remain.  Placing particular emphasis on the constraints imposed by TRIPS as well as the poor state of most public health systems in Southern countries, the contributing authors provide a comprehensive analysis of the huge barriers that have yet to be overcome in order to attain free access to care and offer innovative suggestions of how they might be confronted. In doing this, the book renews our understanding of the political economy of HIV/AIDS in these vast regions, where the disease continues to spread with devastating social and economic consequences.  This volume will be a valuable addition to the current literature on HIV/AIDS in developing countries and will find widespread appeal amongst students and academics studying economics, sociology and public health. It will also be of interest to international organizations and professional associations involved in the fight against pandemics.
000026413 63000 $$aAgreement on Trade-Related Aspects of Intellectual Property Rights.
000026413 650_0 $$aAIDS (Disease)$$xEconomic aspects$$zDeveloping countries.
000026413 650_0 $$aHealth services accessibility$$zDeveloping countries.
000026413 650_0 $$aHIV (Viruses)$$xEconomic aspects$$zDeveloping countries.
000026413 650_0 $$aMedical policy$$zDeveloping countries.
000026413 650_0 $$aPublic health$$zAfrica.
000026413 650_4 $$aPublic health
000026413 651_0 $$aDeveloping countries$$xCommerce$$xLaw and legislation.
000026413 651_0 $$aIndia$$xCommerce$$xLaw and legislation.
000026413 651_0 $$aBrazil$$xCommerce$$xLaw and legislation.
000026413 651_0 $$aThailand$$xCommerce$$xLaw and legislation.
000026413 651_0 $$aAfrica$$xCommerce$$xLaw and legislation.
000026413 7001_ $$aM. Camara,$$aM. Cassier,$$aJ. Chauveau,$$aB. Coriat,$$aM. Correa,$$aM.H. Costa-Couto,$$aC. de Albuquerque Possas,$$aC. d’Almeida,$$aE. Delaporte,$$aK. Diop,$$aS. Fleury,$$aK.A. Freedberg,$$aL. Hasenclever,$$aS. Koulla-Shiro,$$aG. Krikorian,$$aJ. Larmarange,$$aB. Larouzé,$$aG. Le Loup,$$aS. Luchini,$$aC.M. Meiners,$$aJ.-P. Moatti,$$aF. Orsi,$$aA. Robine,$$aK. Rochel de Camargo Jr.,$$aC.E. Sloan,$$aC. Sweet,$$aB. Taverne,$$aJ.-C. Thoenig,$$aB. Ventelou,$$aY. Videau,$$aP. Vinard,$$aY. Yazdanpanah.$$eContributors.
000026413 942__ $$cMON$$jG 99 COR.P
000026413 952__ $$w2011-03-11$$p2011-0216$$r71.96$$u40689$$bMAIN$$10$$kG 99 COR.P$$v2011-03-11$$ztagged$$71
000026413 980__ $$aBIB
000026413 999__ $$c28806$$d28806